当前位置：药药网 / 数据中心 /靶点针对疾病信息(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息12(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Aldose reductase (AKR1B1)
INDICATI
Approved Neuropathy [ICD-11: 8C0Z]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Phase 3 Acute diabete complication [ICD-11: 5A2Y]
INDICATI
Phase 2/3 Thrombosis [ICD-11: DB61-GB90]
INDICATI
Phase 1 Cataract [ICD-11: 9B10]
INDICATI
Discontinued in Phase 3 Gout [ICD-11: FA25]
INDICATI
Discontinued in Phase 2 Head and neck cancer [ICD-11: 2D42]